EVALUATION OF INTRAMUSCULAR BENZATHINE PENICILLIN USE AND TREATMENT OUTCOMES IN CONGENITAL SYPHILIS PATIENTS
EVALUATION OF INTRAMUSCULAR BENZATHINE PENICILLIN USE AND TREATMENT OUTCOMES IN CONGENITAL SYPHILIS PATIENTS

EVALUATION OF INTRAMUSCULAR BENZATHINE PENICILLIN USE AND TREATMENT OUTCOMES IN CONGENITAL SYPHILIS PATIENTS

Pediatr Infect Dis J. 2025 May 30. doi: 10.1097/INF.0000000000004885. Online ahead of print.

ABSTRACT

To identify areas for improvement, this retrospective observational analysis examines syphilis treatment and subsequent follow-up practices amid a nationwide intramuscular penicillin G benzathine (BPG) shortage. Outcomes from 94 neonates confirm the value of BPG in the management of congenital syphilis, reveal opportunities for provider education and highlight the need to reserve BPG for neonates in times of shortage.

PMID:40444955 | DOI:10.1097/INF.0000000000004885